Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Malvern Instruments Launches Viscosizer 200 - a New Analytical Instrument for Biopharmaceutical Development
Thursday, August 01, 2013
Automated viscosity and molecular sizing using less than 10 µL sample.

Measure Molecular Size of Proteins & Polymers
Tuesday, July 23, 2013
Easy and fast measurement of intrinsic viscosity with m-VROC.

Dolomite Presents New Range of Piezoelectric Pumps
Wednesday, July 17, 2013
High performance in miniature format.

Secure Storage of Blood Fraction Samples
Tuesday, July 02, 2013
Biobank Uppsala has reported on its use of 2D-coded sample storage tubes, racks and caps from Micronic to provide traceable, high integrity storage of blood fraction samples.

Dolomite Expertise Brings Microfluidic Product to Market
Monday, June 24, 2013
Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills.

Fluxion Delivers First Commercial Shipments of IsoFlux™ System
Friday, June 07, 2013
Platform enables pharma, research, and diagnostic companies to utilize blood samples for cancer diagnostic breakthroughs.

Dolomite Expertise Brings Microfluidic Product to Market
Friday, May 17, 2013
Mitos Dropix - Dolomite's new droplet-on-demand system.

A*STAR and Veredus Announces Launch of VereTrop™
Friday, April 26, 2013
First lab-on-chip for the detection of multiple tropical infectious diseases.

Dolomite Introduces Next Generation of Microfluidic Connectors and Interfaces
Wednesday, April 24, 2013
Offering high density and outstanding alignment for multiway fluidic connections.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1047
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed